The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: -0.10 (-5.88%)
Spread: 0.20 (13.333%)
Open: 1.65
High: 1.65
Low: 1.60
Prev. Close: 1.70
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

26 Nov 2020 07:00

RNS Number : 5438G
IQ-AI Limited
26 November 2020
 

26 November 2020

IQ-AI Ltd

("IQ-AI" or the "Company")

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

 

IQ-AI today announces that its subsidiary, Imaging Biometrics®, LLC (IB), has made available release 20.11 of its IB Clinic™ software platform. The new release incorporates multiple new enhancement requests received from clients, as well as workflow efficiencies engineered by IB's developers. Ultimately, this release underscores IB's commitment to quality and helping clinicians improve care for their patients.

 

IB Clinic consists of perfusion weighted imaging and permeability computation modules IB Neuro and IB DCE, diffusion weighted imaging analysis module IB Diffusion, image co-registration and manipulation module IB Delta Suite, and IB Rad Tech, which streamlines and automates customizable workflows. While the products contained in IB Clinic continue to be available as plugins to the Mac-based medical imaging viewers, aycan workstation and OsiriX MD, they are also now available as platform-independent automated applications for both in-house and cloud-based processing. Both options generate consistent quantitative output regardless of where or when a patient is scanned, a feature unique to IB Clinic.

 

"This latest release further builds upon our proven track record of delivering scientifically proven advancements to clinicians," said Michael Schmainda, CEO of IB.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

ABOUT Imaging Biometrics, LLC

Imaging Biometrics®, a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat disease with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent and automated software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBABLTMTMTBIM
Date   Source Headline
17th Apr 201511:00 amRNSPreliminary Results
11th Mar 20152:16 pmRNSResult of EGM
13th Feb 20157:00 amRNSBoard Changes and Notice of EGM
31st Dec 20147:00 amRNSUpdate
7th Nov 20143:24 pmRNSSale of Retreat Farm
27th Aug 20147:00 amRNSInterim Results Announcement
11th Jun 201411:42 amRNSResult of AGM
29th Apr 20143:33 pmRNSAnnual Report and Results Announcement
8th Apr 20147:00 amRNSDirectorate Change
9th Jan 201411:30 amRNSDirectorate Change
15th Nov 20137:00 amRNSInterim Management Statement
28th Aug 20137:00 amRNSHalf Yearly Report
13th Jun 20137:00 amRNSResult of AGM
26th Apr 20137:00 amRNSAnnual Report and Results Announcement
25th Apr 20134:59 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jan 20131:31 pmRNSRefinancing of Flowers Direct and Board changes
19th Nov 20127:00 amRNSTrading Update
31st Aug 20127:00 amRNSHalf Yearly Report
1st Aug 20127:00 amRNSClosure of Growing and Live Dispatch Business
9th Jul 20127:00 amRNSDisposal
13th Jun 201210:25 amRNSResult of AGM
6th Jun 20128:05 amRNSTransfer to Standard Listing
28th May 20123:03 pmRNSMerger Update
22nd May 201211:15 amRNSInterim Management Statement
16th May 20122:00 pmRNSMerger Update
4th May 201210:27 amRNSResult of EGM
1st May 20127:00 amRNSCompletion of Sale
30th Apr 20126:36 pmRNSFinal Results- Replacement
30th Apr 20127:00 amRNSAnnual Results Announcement
27th Apr 201211:47 amRNSResult of EGM
11th Apr 20124:24 pmRNSPosting of Circular and Notices of two EGMs
5th Apr 201211:34 amRNSRe. Flowers Direct
30th Mar 20127:54 amRNSPurchase of Assets
30th Mar 20127:00 amRNSProposed disposals
20th Mar 20123:00 pmRNSMerger Update
21st Feb 20127:59 amRNSProposed sale of the Gifts Division
24th Jan 20127:00 amRNSTrading Statement
20th Dec 201112:07 pmRNSApproaches for Certain of the Company's Assets
7th Dec 20117:00 amRNSCompletion of disposals
30th Nov 201110:58 amRNSResult of EGM
15th Nov 20117:00 amRNSPosting of Circular to Shareholders
3rd Nov 20117:00 amRNSInterim Management Statement & Directorate Change
26th Sep 20117:00 amRNSProposed sale of certain non-core property assets
23rd Sep 20117:00 amRNSTrading Statement
29th Jul 20117:00 amRNSHalf Yearly Report
21st Apr 20112:42 pmRNSResult of AGM
21st Apr 20117:00 amRNSContract win with Debenhams
13th Apr 20117:00 amRNSTrading Statement
10th Mar 201110:42 amRNSProposed Dividend - Clarification
10th Mar 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.